Get started
Work

Erratum: Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice

Year: 2016
Type: erratum
Abstract: Scientific Reports 6: Article number: 26428; published online: 26 May 2016; updated: 07 July 2016 This Article contains errors in the Acknowledgements section. “The authors acknowledge funding support from the National Health and Medical Council of Australia (1004926).” should read: “The authors acknowledge funding support from the National Health and Medical Research Council of Australia (1004926) and Diabetes Australia.
DOI: 10.1038/srep28124
Authors: Linda A. Gallo, Micheal S. Ward, Amelia K. Fotheringham, Aowen Zhuang, Danielle J. Borg, Nicole B. Flemming, Ben M. Harvie, Toni L. Kinneally, Shang-Ming Yeh, Domenica A. McCarthy, Hermann Koepsell, Volker Vallon, Carol Pollock, Usha Panchapakesan, Josephine M. Forbes
Language: English
Subfield: Nephrology
Field: Medicine
Open Access status: gold
Estimated APC paid: $2,690
OpenAlex ID: W3091917247
Cites:
Cited by: 12
Related to: 10